Abstract
Epidemiological models are widely used to analyse the spread of diseases such as the global COVID-19 pandemic caused by SARS-CoV-2. However, all models are based on simplifying assumptions and on sparse data. This limits the reliability of parameter estimates and predictions.
In this manuscript, we demonstrate the relevance of these limitations by performing a study of the COVID-19 outbreak in Wuhan, China. We perform parameter estimation, uncertainty analysis and model selection for a range of established epidemiological models. Amongst others, we employ Markov chain Monte Carlo sampling, parameter and prediction profile calculation algorithms.
Our results show that parameter estimates and predictions obtained for several established models on the basis of reported case numbers can be subject to substantial uncertainty. More importantly, estimates were often unrealistic and the confidence / credibility intervals did not cover plausible values of critical parameters obtained using different approaches. These findings suggest, amongst others, that several models are oversimplistic and that the reported case numbers provide often insufficient information.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the European Union's Horizon 2020 research and innovation program (CanPathPro; Grant no. 686282; E.D., J.H., S.M.), the Federal Ministry of Education and Research of Germany (Grant no. 031L0159C; E.A. & Grant no. 01ZX1705; J.H.), the Federal Ministry of Economic Affairs and Energy (Grant no. 16KN074236; J.V.), and the German Research Foundation (Clusters of Excellence EXC 2047 & EXC 2151; E.R., F.B., J.H.).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The complete implementation (including the respective version of the used toolboxes) and data are available on ZENODO (https://doi.org/10.5281/zenodo.3757227). This includes the MATLAB code as well as the the specification of the parameter estimation problems as PEtab files (with the model in SBML format).
